Rare diseases
Investigational molecules
Locations
Recruiting trials first
120 clinical trials in this condition
Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
CroatiaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
AustriaA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
BulgariaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
AustriaWhat patients should know
Currently, 89 clinical trials are evaluating new treatments for ulcerative colitis, a chronic inflammatory bowel disease affecting the large intestine and rectum. These studies are testing various medications including biologics, small molecule drugs, and novel therapies across multiple countries in Europe and beyond, offering patients opportunities to access experimental treatments while contributing to medical research.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
